Author

King Chan

National Cancer Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Anjali DhalliD· 1 shared Chuong D. HoangiD· 1 shared Edwin J. IwanowicziD· 1 shared Fathi ElloumiiD· 1 shared Frank EchtenkampiD· 1 shared George I KaradimoviD· 1 shared Haiqing FuiD· 1 shared Jaydira Del RiveroiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anjali DhallORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

TR-107, a novel mitochondrial ClpP agonist, induces robust antitumor activity against preclinical models of adrenocortical carcinoma

George I Karadimov, Yoo Sun Kim, Haiqing Fu, Sidhant Narula, Fathi Elloumi, Anjali Dhall, Frank Echtenkamp, Luowei Li, Edwin J. Iwanowicz, Lee M. Graves, King Chan, Þorkell Andrésson, Robert W. Robey, Yoshimi Endo Greer, Stanley Lipkowitz, , Jaydira Del Rivero

This study evaluates TR-107, a mitochondrial ClpP agonist, showing antitumor effects in ACC cell lines and organoids, with synergistic activity when combined with IGF-1R inhibitors.

bioRxiv · Aug 11, 2026 · PreprintCancer Biology